Case Report: Tackling Complement Hyperactivation With Eculizumab in Atypical Hemolytic Uremic Syndrome Triggered by COVID-19

Hemolytic uremic syndrome (HUS) is a rare life-threatening disease of unrestrained complement system dysregulation, microangiopathic hemolytic anemia, thrombocytopenia, and acute renal failure in genetically predisposed individuals. In this report, we describe two cases of SARS-CoV-2–associated HUS...

Descripción completa

Detalles Bibliográficos
Autores principales: Leone, Valentina Fanny, Imeraj, Amantia, Gastoldi, Sara, Mele, Caterina, Liguori, Lucia, Condemi, Carmelita, Ruggenenti, Piero, Remuzzi, Giuseppe, Carrara, Camillo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920243/
https://www.ncbi.nlm.nih.gov/pubmed/35295324
http://dx.doi.org/10.3389/fphar.2022.842473

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920243/
https://www.ncbi.nlm.nih.gov/pubmed/35295324
http://dx.doi.org/10.3389/fphar.2022.842473

Ejemplares similares